SCCM Resource Library-Guidelines: Rapid Sequence Intubation

Video Transcription

Video Summary

Sid Patnawala presents medication-related guidelines for induction agents and neuromuscular blockade. Covering questions 7-10, he discusses the use of induction agents, particularly etomidate, and addresses its lack of significant mortality difference compared to other agents. The panel suggests using induction agents despite no direct evidence for specific unstable patients. Patnawala advises against using corticosteroids with etomidate due to weak evidence and adverse effects. For intubation, the use of neuromuscular blockers with sedatives is recommended for higher success rates, despite low evidence quality. Finally, no significant difference was found between rocuronium and succinylcholine for rapid sequence intubation.

Asset Caption

One-Hour Concurrent Session | New SCCM Guidelines: Rapid Sequence Intubation, Recognizing Critical Illness Outside the ICU, and Glycemic Control for Children and Adults

Meta Tag

Content Type Presentation

Membership Level Professional

Membership Level Select

Year 2024

Keywords

induction agents

etomidate

neuromuscular blockade

intubation

rocuronium

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.